A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Public ClinicalTrials.gov record NCT06767683. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Durability of Treatment Effect of ALKS 2680 in Subjects With Narcolepsy Type 1 and Type 2 and Idiopathic Hypersomnia
Study identification
- NCT ID
- NCT06767683
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Alkermes, Inc.
- Industry
- Enrollment
- 256 participants
Conditions and interventions
Interventions
- ALKS 2680, 10mg Drug
- ALKS 2680, 14mg Drug
- ALKS 2680, 18mg Drug
- ALKS 2680, 4mg Drug
- ALKS 2680, 6mg Drug
- ALKS 2680, 8mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 26, 2025
- Primary completion
- May 31, 2028
- Completion
- May 31, 2028
- Last update posted
- Mar 3, 2026
2025 – 2028
United States locations
- U.S. sites
- 30
- U.S. states
- 16
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alkermes Investigator Site | Phoenix | Arizona | 85054 | Recruiting |
| Alkermes Investigational Site | Little Rock | Arkansas | 72211 | Recruiting |
| Alkermes Investigational Site | Los Angeles | California | 90025 | Recruiting |
| Alkermes Investigator Site | San Francisco | California | 94158 | Recruiting |
| Alkermes Investigational Site | Stanford | California | 94305 | Recruiting |
| Alkermes Investigational Site | Colorado Springs | Colorado | 80918 | Recruiting |
| Alkermes Investigational Site | Brandon | Florida | 33511 | Recruiting |
| Alkermes Investigational Site | Miami | Florida | 33176 | Recruiting |
| Alkermes Investigational Site | Winter Park | Florida | 32789 | Recruiting |
| Alkermes Investigational Site | Atlanta | Georgia | 30328 | Recruiting |
| Alkermes Investigational Site | Macon | Georgia | 31210 | Recruiting |
| Alkermes Investigational Site | Stockbridge | Georgia | 30281 | Recruiting |
| Alkermes Investigational Site | Peoria | Illinois | 61637 | Recruiting |
| Alkermes Investigational Site | Lansing | Michigan | 48911 | Recruiting |
| Alkermes Investigational Site | Sterling Heights | Michigan | 48314 | Recruiting |
| Alkermes Investigational Site | Lincoln | Nebraska | 68506 | Recruiting |
| Alkermes Investigational Site | Middletown | New Jersey | 07748 | Recruiting |
| Alkermes Investigational Site | Denver | North Carolina | 28037 | Recruiting |
| Alkermes Investigational Site | Huntersville | North Carolina | 28708 | Recruiting |
| Alkermes Investigational Site | Canton | Ohio | 44718 | Recruiting |
| Alkermes Investigational Site | Cincinnati | Ohio | 45212 | Recruiting |
| Alkermes Investigational Site | Cincinnati | Ohio | 45245 | Recruiting |
| Alkermes Investigational Site | Dublin | Ohio | 43017 | Recruiting |
| Alkermes Investigational Site | Abington | Pennsylvania | 19001 | Recruiting |
| Alkermes Investigational Site | Wyomissing | Pennsylvania | 19610 | Recruiting |
| Alkermes Investigational Site | Columbia | South Carolina | 29201 | Recruiting |
| Alkermes Investigational Site | Austin | Texas | 78731 | Recruiting |
| Alkermes Investigational Site | San Antonio | Texas | 78229 | Recruiting |
| Alkermes Investigational Site | Sugar Land | Texas | 77478 | Recruiting |
| Alkermes Investigational Site | Madison | Wisconsin | 53706 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06767683, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 3, 2026 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06767683 live on ClinicalTrials.gov.